Anumana announced today that it brought its diagnostic ECG-AI technology into perioperative and acute cardiac care with help from Boston Scientific.
Anumana expands AI cardiac care platform with support from Boston Scientific
Related Articles
Turning ECG Data into Actionable Insight with AI
For decades, the ECG has been a fundamental yet relatively limited diagnostic tool in cardiovascular medicine. However, AI-enabled technologies are shifting this paradigm by extracting layers of hidden biological signals…June 26, 2026
Charting a Path to the Right Diagnosis with AI Copilots
The rapid growth and widespread adoption of large language models (LLMs) across real-world applications offer a host of new opportunities for the healthcare sector. Hospitals and clinics are starting to…October 24, 2025
New Project Trains AI on a Hard-to-Diagnose Cardiac Issue
Health Leaders: A start-up from the Mayo Clinic orbit is partnering with Pfizer to develop an AI-enhanced ECG that can detect cardiac amyloidosis, a progressive disease that's difficult to diagnose…December 16, 2022
AI-powered device to identify low LV ejection fraction gains FDA 510(k) clearance
Healio: An AI-powered device to identify low left ventricular ejection fraction in patients at risk for HF gained 510(k) clearance from the FDA.October 02, 2023


